Protection of human pancreatic islets using a lentiviral vector expressing two genes: cFLIP and GFP

Elizabeth S. Fenjves, M. Sofia Ochoa, Sirlene Cechin, Carlota Gay-Rabinstein, Ingrid Pérez-Alvarez, Hirohito Ichii, Armando Mendez, Camillo Ricordi, Michael A. Curran

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Pancreatic islet transplantation can provide insulin independence to diabetic patients. However, apoptosis of islets often leads to early graft failure. Genetic engineering with protective gene(s) can improve the viability of these cells. Here we show successful transduction of human islets with a feline immunodeficiency virus (FIV) vector expressing both a cytoprotective (cFLIP) gene and the green fluorescent protein (GFP). Despite using low virus titers to maximize safety, transduced islets expressed both genes, resulting in improved β-cell metabolic activity and viability. Although only ∼10% of total islet cells were transduced, the significant viability advantages suggest a "barrier" effect in which protecting the periphery of the islet shields the core. These results provide the first demonstration that a lentiviral vector can express two genes in islets. Furthermore, the engineered islets are resistant to a variety of apoptotic stimuli, suggesting the potential of this approach in enhancing the viability of transplanted cells.

Original languageEnglish (US)
Pages (from-to)793-802
Number of pages10
JournalCell transplantation
Issue number7
StatePublished - 2008


  • cFLIP
  • Diabetes
  • Feline immunodeficiency virus (FIV)
  • Gene therapy
  • Pancreatic islet transplantation

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation
  • Biomedical Engineering


Dive into the research topics of 'Protection of human pancreatic islets using a lentiviral vector expressing two genes: cFLIP and GFP'. Together they form a unique fingerprint.

Cite this